Dozens of companies and public labs around the world are working to develop a vaccine to prevent the spread of the flu-like virus.
Over the last 48 hours, three biotech companies, in particular, have been thrust into the spotlight for their promise: BioNTech, CureVac and Moderna.
Moderna is a Massachusetts-based biotech company working with the U.S. National Institutes of Health . It kicked off its first trial Monday in Seattle, Washington. BioNTech, meanwhile, is a German biotech company which recently announced two strategic partnerships to advance development of a vaccine. It formed a collaboration with Fosun Pharma to advance efforts in China, and with Pfizer to do the same outside China.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Katy Perry Hopes Her Baby Is A Girl, And That Is Perfectly FineKaty Perry Hopes Her Baby Is A Girl, And That Is Perfectly Fine katyperry
続きを読む »
In Sunday debate, Biden hopes to wind it down and Sanders to amp it upJoe Biden is asked during tonight's DemDebate whether or not he would institute a national lockdown. He responds, making a nod to Bernie Sanders' healthcare proposal
続きを読む »
German vaccine company CureVac says no offers from Trump to buy exclusive vaccine accessA German biotech company says it did not receive an offer from President Trump to buy exclusive access to a coronavirus vaccine.
続きを読む »
Coronavirus vaccine trial starts Monday, government official saysA clinical trial evaluating a vaccine designed to protect against the new coronavirus will begin Monday.
続きを読む »
Inside One Scientist's Fight to Contain Coronavirus Using DNADr. Kate Broderick, a molecular geneticist, is developing a vaccine to control coronavirus circulating in humans.
続きを読む »